Lingfeng Min

519 total citations
26 papers, 332 citations indexed

About

Lingfeng Min is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lingfeng Min has authored 26 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Lingfeng Min's work include Pleural and Pulmonary Diseases (4 papers), RNA modifications and cancer (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lingfeng Min is often cited by papers focused on Pleural and Pulmonary Diseases (4 papers), RNA modifications and cancer (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lingfeng Min collaborates with scholars based in China, Sweden and Japan. Lingfeng Min's co-authors include Xingxiang Xu, Xizhi Zhang, Xinchen Sun, Yong Chen, Fang Wang, Changjiang Sun, Tao Wang, Chuanli Ren, Jianqi Yang and Yifan Luo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

Lingfeng Min

24 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfeng Min China 10 127 105 102 66 40 26 332
Qunli Ding China 12 141 1.1× 87 0.8× 199 2.0× 35 0.5× 16 0.4× 39 387
Fatemeh Nili Iran 12 71 0.6× 15 0.1× 84 0.8× 48 0.7× 45 1.1× 76 352
Gunda Leschber Germany 12 130 1.0× 70 0.7× 330 3.2× 106 1.6× 8 0.2× 33 601
A. Forgione Italy 7 51 0.4× 23 0.2× 76 0.7× 53 0.8× 58 1.4× 16 282
Xue Jiang China 12 98 0.8× 27 0.3× 41 0.4× 115 1.7× 27 0.7× 28 368
Jürgen Durner Germany 8 71 0.6× 30 0.3× 19 0.2× 18 0.3× 21 0.5× 19 282
Hai-Bin Chen China 11 79 0.6× 48 0.5× 48 0.5× 65 1.0× 16 0.4× 31 274
Ziyang Zeng China 10 90 0.7× 64 0.6× 104 1.0× 48 0.7× 16 0.4× 32 363
Yanjun Liu China 14 178 1.4× 101 1.0× 42 0.4× 65 1.0× 42 1.1× 54 438
Felix C. Blanco United States 8 107 0.8× 79 0.8× 40 0.4× 22 0.3× 11 0.3× 13 311

Countries citing papers authored by Lingfeng Min

Since Specialization
Citations

This map shows the geographic impact of Lingfeng Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Min more than expected).

Fields of papers citing papers by Lingfeng Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfeng Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Min. The network helps show where Lingfeng Min may publish in the future.

Co-authorship network of co-authors of Lingfeng Min

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfeng Min. A scholar is included among the top collaborators of Lingfeng Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfeng Min. Lingfeng Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhixin, et al.. (2025). Biological characterization and clinical significance of cuproptosis-related genes in lung adenocarcinoma. BMC Pulmonary Medicine. 25(1). 13–13. 1 indexed citations
2.
Ren, Ke, et al.. (2025). The Role of Autophagy and Cell Communication in COPD Progression: Insights from Bioinformatics and scRNA-seq. COPD Journal of Chronic Obstructive Pulmonary Disease. 22(1). 2444663–2444663. 1 indexed citations
3.
Zhou, Liang, Minmin Zhu, Wei Zhang, et al.. (2025). Medical Thoracoscopy With vs Without Prior Artificial Pneumothorax for Patients With Minimal or Absent Pleural Effusion. CHEST Journal. 169(1). 269–279.
6.
Ge, Hui, et al.. (2024). Disulfidptosis-related gene SLC7A11 predicts prognosis and indicates tumor immune infiltration in lung adenocarcinoma. Translational Cancer Research. 13(9). 5064–5072. 1 indexed citations
7.
9.
Liu, Hongjun, Xiaolin Wang, Liping Wang, et al.. (2023). Associative analysis of multi-omics data indicates that acetylation modification is widely involved in cigarette smoke-induced chronic obstructive pulmonary disease. Frontiers in Medicine. 9. 1030644–1030644. 4 indexed citations
10.
Feng, Tingting, et al.. (2022). Chronic exposure to IQOS results in impaired pulmonary function and lung tissue damage in mice. Toxicology Letters. 374. 1–10. 8 indexed citations
11.
Feng, Tingting, et al.. (2020). Rare cause of repeated pulmonary embolism: a case of primary pleural squamous cell carcinoma and literature review. BMC Pulmonary Medicine. 20(1). 75–75. 2 indexed citations
12.
Wang, Tao, Jie Yu, Caiyun Zhu, et al.. (2019). <p>The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies</p>. Drug Design Development and Therapy. Volume 13. 539–553. 23 indexed citations
13.
Feng, Tingting, et al.. (2019). The clinical responses of TNIP2-ALK fusion variants to crizotinib in ALK-rearranged lung adenocarcinoma. Lung Cancer. 137. 19–22. 11 indexed citations
14.
Gu, Jianjun, et al.. (2019). The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung. Cancer Medicine. 8(6). 2979–2993. 34 indexed citations
15.
Xu, Xingxiang, et al.. (2018). Rab6A GTPase contributes to phenotypic modulation in pulmonary artery smooth muscle cells under hypoxia. Journal of Cellular Biochemistry. 120(5). 7858–7867. 8 indexed citations
16.
Min, Lingfeng, et al.. (2017). Menopausal status and the risk of lung cancer in women. Medicine. 96(26). e7065–e7065. 11 indexed citations
17.
Wang, Fang, et al.. (2017). Height and lung cancer risk: A meta-analysis of observational studies. PLoS ONE. 12(9). e0185316–e0185316. 8 indexed citations
18.
Chen, Yong, Lingfeng Min, Chuanli Ren, et al.. (2017). miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer. PLoS ONE. 12(2). e0171751–e0171751. 89 indexed citations
19.
Bai, Hua, Hirotomo Nakaoka, Kana Tsukuda, et al.. (2016). Synergistic Inhibitory Effect of Rosuvastatin and Angiotensin II Type 2 Receptor Agonist on Vascular Remodeling. Journal of Pharmacology and Experimental Therapeutics. 358(2). 352–358. 6 indexed citations
20.
Min, Lingfeng, Xingxiang Xu, Yong Song, et al.. (2012). Breath-hold after forced expiration before removal of the biopsy needle decreased the rate of pneumothorax in CT-guided transthoracic lung biopsy. European Journal of Radiology. 82(1). 187–190. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026